While taking semaglutide may help you lose weight while you are on the drug, most people will regain most of that weight if they discontinue using it
That distinction matters because younger patients require separate pathways, separate evidence and, in some cases, different approved products
Coverage through Medicaid, meanwhile, has varied from state to state, with at least 14 states covering the cost of GLP-1 medications for obesity treatment for patients
Both peptides are chemically compatible in the same syringe and do not degrade each other
These factors affect results including waist circumference, blood lipids, and visceral versus subcutaneous fat ratios
If InBody shows continued SMM decline despite protein targets being met and resistance training prescribed, consider three possibilities: (1) the caloric deficit may be too aggressive consider slowing the rate of weight loss by reducing the deficit